Port Talbot firm Cultech develops IBS treatment
Dec 15 2008 by Madeleine Brindley, Western Mail
www.walesonline.co.uk

A NEW strain of probiotic has been discovered in Wales which could help people suffering from irritable bowel syndrome.

The discovery by the Port Talbot-based probiotic manufacturer Cultech could offer fresh hope to more than 200,000 sufferers living with the condition in South Wales alone.

Research by the University of Sheffield revealed that people with IBS who took LAB4 – now available under the brand name ProVen – noticed improvements in their condition.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used in the management of osteoarthritis. However, there is limited evidence that they actually improve the underlying pathology of the condition. Moreover, adverse effects are common, limiting their long-term use.

Glucosamine is an intermediate substrate used in the synthesis of glycosaminoglycans and proteoglycans by articular cartilage. Glucosamine is classified as a slow-acting drug in osteoarthritis and stands out as the most efficacious chondroprotective agent currently available. The nutrient has also demonstrated mild anti-inflammatory activity.